"Reeprima 0.2%" is distributed as 1 x 1.1mL syringe, giving purchasing managers a fixed packaging reference for forecasting. "Reeprima 0.2%" addresses micro-repair signaling and barrier-quality restoration through PDRN-mediated repair, making it suitable for medically supervised booster pathways.